Clinical Research Centre (CRC), Hospital Raja Permaisuri Bainun, Ministry of Health, Level 4, Ambulatory Care Centre (ACC), Jalan Raja Ashman Shah, 30450, Ipoh, Perak, Malaysia.
Clinical Research Centre (CRC), Hospital Sultanah Bahiyah, Ministry of Health, Km6, 256, 05460, Alor Setar, Kedah, Malaysia.
BMC Musculoskelet Disord. 2022 Apr 28;23(1):400. doi: 10.1186/s12891-022-05354-1.
Chronic pain has a major impact on a patient's quality of life, affecting physical and psychological functioning. It has debilitating consequences on social and economic aspects too. This study aimed to explore the status of health-related quality of life (HRQoL) of Malaysian patients suffering from chronic non-malignant pain.
Four hospitals offering pain clinic services were involved in this multicentre cross-sectional study conducted between June and September 2020. Adult patients who had been diagnosed with non-malignant chronic pain lasting for at least three months and able to communicate in English or Malay language were recruited in this study. Participants were informed about the study and were made aware that their participation was entirely voluntary. A battery of questionnaires consists of the EuroQol-5 dimensions-5 levels questionnaire (EQ-5D-5L) and the EuroQol visual analogue scale (EQ VAS), the Pain Self-Efficacy questionnaire (PSEQ) and the Pain Catastrophizing Scale (PCS) were self-administered by the patients. Besides, a structured questionnaire was used to collect their socio-demographic information, pain condition, sleep quality and working status. Participants' usage of pain medications was quantified using the Quantitative Analgesic Questionnaire (QAQ).
A total of 255 patients participated in this study. A median EQ-5D index value of 0.669 (IQR: 0.475, 0.799) and a median EQ VAS score of 60.0 (IQR: 50.0, 80.0) were recorded. Malay ethnicity (Adj. B: 0.77; 95% CI: 0.029, 0.126; p = 0.002) and a higher level of self-efficacy (Adj. B: 0.008; 95% CI: 0.006, 0.011; p < 0.001) were predictors of a better HRQoL, while suffering from pain in the back and lower limb region (Adj. B: -0.089; 95% CI: - 0.142, - 0.036; p = 0.001), the use of a larger amount of pain medications (Adj. B: -0.013; 95% CI: - 0.019, - 0.006; p < 0.001), and a higher degree of pain magnification (Adj. B: -0.015; 95% CI: - 0.023, - 0.008; p < 0.001) were associated with a poorer HRQoL.
These findings suggested that Malay ethnicity and a higher level of self-efficacy were predictors of a better HRQoL in patients with chronic pain, whereas pain-related factors such as higher usage of medication, specific pain site and pain magnification style were predictors of poorer HRQoL.
慢性疼痛对患者的生活质量有重大影响,影响身体和心理功能。它对社会和经济方面也有衰弱的影响。本研究旨在探讨马来西亚慢性非恶性疼痛患者的健康相关生活质量(HRQoL)状况。
本项多中心横断面研究于 2020 年 6 月至 9 月在 4 家提供疼痛诊所服务的医院进行。招募了患有持续至少 3 个月的非恶性慢性疼痛且能够用英语或马来语交流的成年患者。告知患者研究情况,并让他们知道他们的参与完全是自愿的。患者自行填写一套问卷,包括欧洲五维健康量表 5 维度 5 水平问卷(EQ-5D-5L)和欧洲五维健康量表视觉模拟量表(EQ VAS)、疼痛自我效能问卷(PSEQ)和疼痛灾难化量表(PCS)。此外,还使用结构化问卷收集了他们的社会人口统计学信息、疼痛状况、睡眠质量和工作状况。使用定量镇痛问卷(QAQ)量化参与者的疼痛药物使用情况。
共有 255 名患者参加了这项研究。记录到中位 EQ-5D 指数值为 0.669(IQR:0.475,0.799)和中位 EQ VAS 得分为 60.0(IQR:50.0,80.0)。马来族裔(调整后的 B:0.77;95%CI:0.029,0.126;p=0.002)和更高的自我效能感(调整后的 B:0.008;95%CI:0.006,0.011;p<0.001)是 HRQoL 更好的预测因素,而背部和下肢疼痛(调整后的 B:-0.089;95%CI:-0.142,-0.036;p=0.001)、使用更多的疼痛药物(调整后的 B:-0.013;95%CI:-0.019,-0.006;p<0.001)和更高程度的疼痛放大(调整后的 B:-0.015;95%CI:-0.023,-0.008;p<0.001)与较差的 HRQoL 相关。
这些发现表明,马来族裔和更高的自我效能感是慢性疼痛患者 HRQoL 更好的预测因素,而与疼痛相关的因素,如更高的药物使用、特定的疼痛部位和疼痛放大方式,是 HRQoL 较差的预测因素。